Today, we’re diving into GLP‑1 therapies, including dual GIP/GLP‑1 agonists and the emerging triple agonists, and talking about how these peptides are typically dosed, what people are experimenting with, and what the research — or real-world experience — tells us so far. Most GLP‑1 receptor agonists, as well as dual and triple agonists, are designed […]
Retatrutide
How Retatrutide Compares to Semaglutide and Tirzepatide
In this episode, we’re unpacking the latest on retatrutide and how it measures up against semaglutide and tirzepatide. If you want to support what we do, head over to our Partners Page. You’ll find some amazing brands we trust—and by checking them out, you’re helping us keep the podcast going. We’ll look closely at what […]